NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and certain of the Company's senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc. Investors have until December 16, 2024 to ask the Court to be appointed to lead the case. The c ...

Lawsuit Overview - Leading securities law firm Bleichmar Fonti & Auld LLP has filed a lawsuit against Acadia Healthcare Company, Inc and certain senior executives [1] - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Acadia Healthcare's securities [2] - Investors have until December 16, 2024 to ask the Court to be appointed to lead the case [2] Allegations Against Acadia Healthcare - Acadia Healthcare is accused of misrepresenting its financial results, which were allegedly driven by insurance fraud and holding vulnerable people against their will in its facilities, even when not medically necessary [3] - The New York Times investigation found that Acadia has lured patients into its facilities and held them against their will, even when detaining them was not medically necessary [4] - The Veterans Affairs Department is investigating whether Acadia is defrauding government health insurance programs by holding patients longer than is medically necessary [6] Impact on Stock Price - Following the New York Times article on September 1, 2024, Acadia's stock price fell $3 72 per share, or 4 5%, to close at $78 21 per share on September 3, 2024 [4] - On September 27, 2024, Acadia disclosed receiving requests for information from the U S Attorney's Office and a grand jury subpoena, causing a 16% decline in stock price from $75 66 to $63 28 per share [5] - The New York Times article on October 18, 2024, about the Veterans Affairs Department investigation caused a 12% decline in Acadia's stock price from $59 32 to $52 03 per share [6] Legal Actions and Investigations - Acadia received a request for information from the U S Attorney's Office for the Southern District of New York and a grand jury subpoena from the U S District Court for the Western District of Missouri [5] - The company expects similar requests from the U S Securities and Exchange Commission related to its patient admissions, length of stay, and billing practices [5] - Several former Acadia employees in Georgia and Missouri have been interviewed by agents from the F B I and the inspector general's office of the Health and Human Services Department [6]

SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) publicly traded securities between February 28, 2020 and October 18, 2024, both dates inclusive (the “Class Period”), have until December 16, 2024 to seek appointment as lead plaintiff of the Acadia Healthcare class action lawsuit. Captioned Kachrodia v. Acadia Healthcare Company, Inc., No. 24-cv-01238 (M.D. Tenn.), the Acadia ...

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Q3 2024 Earnings Conference Call October 31, 2024 9:00 AM ET Company Participants Patrick Feeley – Head-Investor Relations Chris Hunter – Chief Executive Officer Heather Dixon – Chief Financial Officer Conference Call Participants A.J. Rice – UBS Whit Mayo – Leerink Partners Brian Tanquilut – Jefferies John Ransom – Raymond James Christian Porter – Bank of America Ben Hendrix – RBC Capital Markets Pito Chickering – Deutsche Bank Andrew Mok – Barclays Sarah James ...

RADNOR, Pa., Oct. 31, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Middle District of Tennessee against Acadia Healthcare Company, Inc. (“Acadia Healthcare”) (NASDAQ: ACHC) on behalf of investors who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and October 18, 2024, inclusive (the “Class Period”) The lead p ...

BOSTON, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Block & Leviton announces that a securities fraud lawsuit has been filed against Acadia Healthcare Company, Inc. (Nasdaq: ACHC) and certain of its executives. Investors who have lost money in their Acadia Healthcare Company, Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/achc. What is this all about? Acadia Healthcare has been sued for violations of the securitie ...

NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and certain of the Company’s senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc. Investors have until December 16, 2024 to ask the Court to be appointed to lead the case. The c ...

Acadia Healthcare (ACHC) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.90 per share. This compares to earnings of $0.91 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 1.11%. A quarter ago, it was expected that this provider of inpatient behavioral health care services would post earnings of $0.88 per share when it actually produced earnings of $0.91, delivering a surprise of ...

Exhibit 99 ACADIA HEALTHCARE REPORTS STRONG THIRD QUARTER 2024 RESULTS PROVIDES UPDATED GUIDANCE FOR 2024 FRANKLIN, Tenn. (October 30, 2024) – Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the third quarter and nine months ended September 30, 2024. Third Quarter Highlights ● Revenue totaled $815.6 million, an increase of 8.7% over the third quarter of 2023 ● Same facility revenue increased 8.6% compared with the third quarter of 2023, including an increase in revenue p ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-35331 Acadia Healthcare Company, Inc. (Exact name of registrant as specified in its charter) Dela ...